Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 5Breast Neoplasms 5Stomach Neoplasms 3Neoplasms 3Malnutrition 3Lung Neoplasms 3Diarrhea 3Mucositis 2Enteritis 2Chalazion 2Carcinoma, Hepatocellular 2Thyroid Neoplasms 1Squamous Intraepithelial Lesions 1Smoldering Multiple Myeloma 1Psychological Well-Being 1Polycystic Ovary Syndrome 1Periampullary Carcinoma Nos 1Pelvic Neoplasms 1Papillomavirus Infections 1Ovarian Neoplasms 1Neoplasms, Second Primary 1Muscle Invasive Bladder Cancer (MIBC) 1Multiple Myeloma 1Motor Activity 1Monoclonal Gammopathy of Undetermined Significance 1Liver Cirrhosis 1Limited Stage Small Cell Lung Cancer 1Laryngeal Neoplasms 1Inflammation 1Infections 1

Interventions

Human Papillomavirus Recombinant Vaccine nonavalent 9Papillomavirus Vaccines 8Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 8Surveys and Questionnaires 6Educational Status 6Blood Specimen Collection 5Vaginal Smears 4Radiotherapy, Intensity-Modulated 4Methods 4Human Papillomavirus DNA Tests 4Early Intervention, Educational 4Cisplatin 4Carboplatin 4Patient Navigation 3Mass Screening 3Taxes 2Standard of Care 2Radiation 2Practice Guidelines as Topic 2Papanicolaou Test 2Paclitaxel 2Motivational Interviewing 2Interviews as Topic 2Electrocoagulation 2Docetaxel 2Cytological Techniques 2Cryotherapy 2Colposcopy 2utomilumab 1toripalimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Papillomavirus Infections × Probiotics × Clear all
NCT05316064 2024-05-10

Reducing Abundance of Human Papilloma Virus in Women by Taking Probiotic

Universiti Sains Malaysia

Phase 2/3 Withdrawn

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡